CAS: 24584-09-6 - Dexrazoxane
Formula:C11H16N4O4
InChI:InChI=1S/C11H16N4O4/c1-7(15-5-10(18)13-11(19)6-15)2-14-3-8(16)12-9(17)4-14/h7H,2-6H2,1H3,(H,12,16,17)(H,13,18,19)/t7-/m0/s1
InChI key:InChIKey=BMKDZUISNHGIBY-ZETCQYMHSA-N
SMILES:O=C1NC(=O)CN(C1)CC(N2CC(=O)NC(=O)C2)C
- Synonyms:
- 4,4'-(2S)-Propan-1,2-diyldipiperazin-2,6-dion
- 4,4'-(2S)-propane-1,2-diyldipipérazine-2,6-dione
- (+)-1,2-Bis(3,5-dioxopiperazin-1-yl)propane
- Eucardion
- 4,4′-[(1S)-1-Methyl-1,2-ethanediyl]bis[2,6-piperazinedione]
- 2,6-piperazinedione, 4,4'-[(1S)-1-methyl-1,2-ethanediyl]bis-
- 4,4'-(2S)-Propane-1,2-diyldipiperazine-2,6-dione
- 2,6-Piperazinedione, 4,4′-(1-methyl-1,2-ethanediyl)bis-, (S)-
- 2,6-Piperazinedione, 4,4′-propylenedi-, (+)-
- (+)-4,4'-Propylenedi-2,6-piperazinedione
- See more synonyms
- (+)-4,4'-(1-Methyl-1,2-ethanediyl)bis-2,6-piperazinedione
- 4,4'-[(2S)-1,2-Propanediyl]di(2,6-piperazinedione)
- (S)-4,4'-(1-METHYL-1,2-ETHANEDIYL)BIS-2,6-PIPERAZINEDIONE
- 2,6-Piperazinedione, 4,4′-[(1S)-1-methyl-1,2-ethanediyl]bis-
2,6-Piperazinedione, 4,4'-[(1S)-1-methyl-1,2-ethanediyl]bis-
CAS:24584-09-6
Formula:
C11H16N4O4
Purity:
95%
Color and Shape:
Solid
Molecular weight:
268.2691
Ref: IN-DA002ONZ
1g | 170.00 € | ||
5g | 558.00 € | ||
25g | To inquire | ||
10mg | 23.00 € | ||
25mg | 43.00 € | ||
50mg | 47.00 € | ||
100mg | 57.00 € | ||
250mg | 79.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Dexrazoxane ((S)-Razoxane)
CAS:24584-09-6
Formula:
C11H16N4O4
Color and Shape:
White To Off-White Solid
Molecular weight:
268.27
Ref: 4Z-R-088001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Dexrazoxane
CAS:24584-09-6
Formula:
C11H16N4O4
Purity:
>98.0%(T)
Color and Shape:
White to Light yellow to Light orange powder to crystal
Molecular weight:
268.27
Ref: 3B-D4227
100mg | 29.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Dexrazoxane
CAS:24584-09-6
Dexrazoxane (ICRF-187) is a mitosis-blocking anticancer drug, iron chelator, and anthracycline cardioprotectant.
Formula:
C11H16N4O4
Purity:
99.45%
Color and Shape:
Solid
Molecular weight:
268.27
Ref: TM-T22305
25mg | 46.00 € | ||
50mg | 62.00 € | ||
100mg | 88.00 € | ||
500mg | 187.00 € | ||
1mL*10mM (DMSO) | 49.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Dexrazoxane
CAS:24584-09-6
Formula:
C11H16N4O4
Purity:
≥ 98.0% (dried basis)
Color and Shape:
White to off-white, pale yellow or beige powder or crysals
Molecular weight:
268.27
Ref: 7W-GP2739
100mg | 60.00 € | ||
250mg | 112.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Dexrazoxane
Controlled ProductCAS:24584-09-6
Applications Dexrazoxane is a cardioprotective compound against anthracyclines. It is highly protective in reducing anthracycline-induced …
Formula:
C11H16N4O4
Color and Shape:
Neat
Molecular weight:
268.27
Ref: TR-D299050
10mg | 178.00 € | ||
50mg | 241.00 € | ||
250mg | 698.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
(S)-4,4'-(Propane-1,2-diyl)bis(piperazine-2,6-dione)
CAS:24584-09-6
Purity:
95.0%
Color and Shape:
Solid
Molecular weight:
268.27301025390625
Ref: 10-F093447
1g | To inquire | ||
5g | To inquire | ||
25g | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire | ||
250mg | 86.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Dexrazoxane - Bio-X ™
CAS:24584-09-6
Dexrazoxane is a cytoprotective drug that is used in chemotherapy to provide cardio-protection against anthracycline …
Formula:
C11H16N4O4
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
268.27 g/mol
Ref: 3D-BD164365
10mg | 136.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025
Dexrazoxane
CAS:24584-09-6
Topoisomerase II inhibitor; iron chelator
Formula:
C11H16N4O4
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
268.27 g/mol
Ref: 3D-FD65001
1g | 457.00 € | ||
2g | 645.00 € | ||
100mg | 137.00 € | ||
250mg | 193.00 € | ||
500mg | 279.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025